How big is Quanterix Corp.?

As of Jun 18, Quanterix Corp. has a market capitalization of 238.57 million and reported net sales of 135.68 million with a net profit of -47.87 million over the latest four quarters. Shareholder's funds are at 330.04 million, with total assets of 411.74 million as of Dec 24.

As of Jun 18, Quanterix Corp. has a market capitalization of 238.57 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 135.68 million for the latest four quarters. During the same period, it recorded a net profit of -47.87 million.<BR><BR>As of Dec 24, the reporting period for the balance sheet shows shareholder's funds at 330.04 million and total assets amounting to 411.74 million.

What does Quanterix Corp. do?

Quanterix Corp. develops ultra-sensitive digital immunoassay platforms for life science research and diagnostics in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $30 million and a net loss of $21 million, with a market cap of $238.57 million.

Overview:<BR>Quanterix Corp. develops ultra-sensitive digital immunoassay platforms and tools for life science research and diagnostics within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 30 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -21 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 238.57 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.83 <BR>Return on Equity: -13.88% <BR>Price to Book: 0.75<BR><BR>Contact Details:<BR>Address: 900 Middlesex Tpke, BILLERICA MA: 01821-3929 <BR>Tel: 1 617 3019400 <BR>Fax: 1 302 6555049 <BR>Website: https://www.quanterix.com/

Should I buy, sell or hold Quanterix Corp.?

Who are in the management team of Quanterix Corp.?

As of March 2022, the management team of Quanterix Corp. includes E. Kevin Hrusovsky (Chairman, President, CEO), Dr. Martin Madaus (Lead Independent Director), and Independent Directors Keith Crandell, Dr. Marijn Dekkers, Sarah Hlavinka, and Paul Meister. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Quanterix Corp. includes:<BR><BR>- Mr. E. Kevin Hrusovsky, who serves as the Chairman of the Board, President, and Chief Executive Officer.<BR>- Dr. Martin Madaus, who is the Lead Independent Director.<BR>- Mr. Keith Crandell, an Independent Director.<BR>- Dr. Marijn Dekkers, also an Independent Director.<BR>- Sarah Hlavinka, who holds the position of Independent Director.<BR>- Mr. Paul Meister, another Independent Director. <BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Is Quanterix Corp. technically bullish or bearish?

As of September 2, 2025, Quanterix Corp. is in a bearish trend with weak momentum indicators, underperforming the S&P 500 significantly with a year-to-date return of -47.51% compared to the S&P's 12.22%.

As of 2 September 2025, the technical trend for Quanterix Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the monthly MACD and KST both showing bearish signals. The daily moving averages are also mildly bearish, while the weekly Bollinger Bands are bullish, creating a mixed signal. The stock has underperformed significantly compared to the S&P 500 over multiple periods, with a year-to-date return of -47.51% versus the S&P 500's 12.22%, and a one-year return of -60.54% compared to the S&P 500's 17.14%.